Search results
25 wrz 2024 · Treatment is guided by staging and prognosis. Treatment options include resection, transplantation, percutaneous ablation therapy, chemoembolisation, and systemic immunotherapy. Atezolizumab plus bevacizumab, or durvalumab plus tremelimumab are the first-line agents for advanced-stage HCC.
Immunotherapy with atezolizumab plus bevacizumab represents the new standard of care in systemic front-line treatment of hepatocellular carcinoma (HCC). However, biomarkers that predict treatment success and survival remain an unmet need.
28 kwi 2023 · Hepatocellular carcinoma (HCC) is the most common type of primary liver cancer. Hepatocellular carcinoma occurs most often in people with chronic liver diseases, such as cirrhosis caused by hepatitis B or hepatitis C infection.
As with any cancer, the treatment and prognosis of HCC varies depending on tumor histology, size, how far the cancer has spread, and overall health of the person.
Hepatocellular carcinoma (HCC) is the fourth-leading cause of cancer-related mortality worldwide and the fastest-rising cause of cancer-related death in the United States. Given the strong association between tumor stage and prognosis, HCC surveillance is recommended in high-risk patients, including patients with cirrhosis from any etiology.
13 lut 2024 · How is hepatocellular carcinoma treated? Treatments include: Surgery: The surgical treatments for HCC are hepatectomy (removing the diseased part of your liver) or a liver transplant. You may receive a hepatectomy if the tumor is only limited to one part of your liver.
12 cze 2023 · Hepatocellular carcinoma (HCC) is a primary tumor of the liver and constitutes more than 90% of the primary tumor of the liver. Hepatocellular carcinoma occurs in approximately 85% of patients diagnosed with cirrhosis. [1] . HCC is now the fifth most common cause of cancer worldwide. [2] .
